GlaxoSmithKline Pharmaceuticals Limited — Updates, 29-10-2024: Press Release

GlaxoSmithKline Pharmaceuticals Limited reported revenue of over INR 1000 crores for Q2 2024-25, a 5% increase, with a 15% rise in Profit After Tax to INR 249 crores. For the half year, revenue reached INR 1811 crores, up 7%. The Board declared a special interim dividend of INR 12 per share to celebrate 100 years in India. Key brands maintained market share, with strong performance in vaccines and an awareness campaign for shingles prevention.